Annual Report

Overview

The report describes FY23 consolidated revenue of INR 16,851 mn and a major expansion into dermatology through three acquisitions. It also highlights patient-care initiatives, including large-scale screening and monitoring programs, alongside continued growth in the insulin business. Environmental actions included energy-efficiency measures, zero liquid discharge and recycled-water targets, while the BRSR describes governance, employee and community initiatives.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2022-2023
Period: 1 April 2022 – 31 March 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services